EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Programmed death receptor 1 (PD‐1) ligand Fc fusion proteins reduce T‐cell proliferation in vitro independently of PD‐1

Melissa Biemond iD, David Vremec, Daniel Hd Gray iD, Philip D Hodgkin iD, Susanne Heinzel iD

Immunology & Cell Biology · 2024-02 · 102 (2) · 117-130

DOI: 10.1111/imcb.12714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology & Cell Biology, online erschienen am 09.12.2023. Verfasst von Melissa Biemond und 4 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government, Cancer Council Victoria, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Programmed death receptor 1 (PD‐1) is an inhibitory receptor on T cells shown to restrain T‐cell proliferation. PD‐1 immune checkpoint blockade has emerged as a highly promising approach in cancer treatment. Much of our understanding of the function of PD‐1 is derived from in vitro T‐cell activation assays. Here we set out to further investigate how T cells integrate inhibitory signals such as PD‐1 in vitro using the PD‐1 agonist, PD‐1 ligand 1 (PD‐L1) fusion protein (PD‐L1.Fc), coimmobilized alongside anti‐CD3 agonist monoclonal antibody (mAb) on plates to deliver PD‐1 signals to wild‐type and PD‐1 −/− CD8 + T cells. Surprisingly, we found that the PD‐L1.Fc fusion protein inhibited T‐cell proliferation independently of PD‐1. This PD‐L1.Fc inhibition was observed in the presence and absence of CD28 and interleukin‐2 signaling. Binding of PD‐L1.Fc was restricted to PD‐1–expressing T cells and thus inhibition was not mediated by the interaction of PD‐L1.Fc with CD80 or other yet unknown binding partners. Furthermore, a similar PD‐1–independent reduction of T‐cell proliferation was observed with plate‐bound PD‐L2.Fc. Hence, our results suggest that the coimmobilization of PD‐1 ligand fusion proteins with anti‐CD3 mAb leads to a reduction of T‐cell engagement with plate‐bound anti‐CD3 mAb. This study demonstrates a nonspecific mechanism of T‐cell inhibition when PD‐L1.Fc or PD‐L2.Fc fusion proteins are delivered in a plate‐bound coimmobilization assay and highlights the importance of careful optimization of assay systems and reagents when interpreting their influence on T‐cell proliferation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesProgrammed Cell Death 1 ReceptorB7-H1 AntigenLigandsCell ProliferationReceptors, Death Domain

Stichwörter der Autor:innen

CD8+ T cellsPD-1immune checkpointsnaïve T cell activation

Substanzen

Programmed Cell Death 1 ReceptorB7-H1 AntigenLigandsReceptors, Death Domain

Autor:innen und Institutionen

  • Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.

ORCID-Profile: Melissa Biemond, Daniel Hd Gray, Philip D Hodgkin, Susanne Heinzel

Förderung

  • Australian Government
  • Cancer Council Victoria
  • National Health and Medical Research Council
  • State Government of Victoria

Zitieren

APA

Biemond, M., Vremec, D., Gray, D. H., Hodgkin, P. D., & Heinzel, S. (2024). Programmed death receptor 1 (PD‐1) ligand Fc fusion proteins reduce T‐cell proliferation in vitro independently of PD‐1. Immunology & Cell Biology, 102(2), 117-130. https://doi.org/10.1111/imcb.12714

Vancouver

Biemond M, Vremec D, Gray DH, Hodgkin PD, Heinzel S. Programmed death receptor 1 (PD‐1) ligand Fc fusion proteins reduce T‐cell proliferation in vitro independently of PD‐1. Immunology & Cell Biology. 2024;102(2):117-130. doi:10.1111/imcb.12714

BibTeX
@article{Biemond2024,
  author = {Biemond, Melissa and Vremec, David and Gray, Daniel Hd and Hodgkin, Philip D and Heinzel, Susanne},
  title = {Programmed death receptor 1 (PD‐1) ligand Fc fusion proteins reduce T‐cell proliferation in vitro independently of PD‐1},
  journal = {Immunology & Cell Biology},
  year = {2024},
  volume = {102},
  number = {2},
  pages = {117--130},
  doi = {10.1111/imcb.12714}
}
Kostenlos starten →